Hodgkin disease immunopathogenesis: Long-standing questions, recent answers, further directions

Trends in Immunology

Volumn 24, Issue 9, 2003, Pages 508-511

  Papadaki, Theodora ^a   Stamatopoulos, Kostas ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; BIOAVAILABILITY; CELL MATURATION; CELL SURVIVAL; CLONAL VARIATION; DISEASE COURSE; HODGKIN DISEASE; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PHENOTYPE; REED STERNBERG CELL; REVIEW; STEM CELL; TRANSCRIPTION REGULATION; VIRUS INFECTION;

EID: 0042380007     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00236-9     Document Type: Review

References (45)

1. Pileri S.A., et al. Hodgkin's lymphoma: the pathologist's viewpoint. J. Clin. Pathol. 55:2002;162-176.
2. Küppers R., et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10962-10966.
3. Kanzler H., et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184:1996;1495-1505.
4. Marafioti T., et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N. Engl. J. Med. 337:1997;453-458.
5. Brauninger A., et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N. Engl. J. Med. 340:1999;1239-1247.
6. Marafioti T., et al. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J. Clin. Oncol. 17:1999;3804-3809.
7. Küppers R., et al. Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL. Mol. Med. 7:2001;285-292.
8. Marafioti T., et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 95:2000;1443-1450.
9. Brauninger A., et al. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma. Cancer Res. 63:2003;1644-1651.
10. Stein H., et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 97:2001;496-501.
11. Jundt F., et al. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood. 99:2002;3060-3062.
12. Hertel C.B., et al. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene. 21:2002;4908-4920.
13. Anderson M.K., et al. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity. 16:2002;285-296.
14. Rolink A.G., et al. Selection events operating at various stages in B cell development. Curr. Opin. Immunol. 13:2001;202-207.
15. Maier H., Hagman J. Roles of EBF and Pax-5 in B lineage commitment and development. Semin. Immunol. 14:2002;415-422.
16. Nutt S.L., et al. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int. Rev. Immunol. 20:2001;65-82.
17. Chiang M.Y., Monroe J.G. BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage. Blood. 94:1999;3621-3632.
18. Mikkola I., et al. Reversion of B cell commitment upon loss of Pax5 expression. Science. 297:2002;110-113.
19. Schebesta M., et al. Transcriptional control of B-cell development. Curr. Opin. Immunol. 14:2002;216-223.
20. Foss H.D., et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood. 94:1999;3108-3113.
21. Schwering I., et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 101:2003;1505-1512.
22. Jundt F., et al. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 99:2002;3398-3403.
23. Souabni A., et al. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity. 17:2002;781-793.
24. Pui J.C., et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 11:1999;299-308.
25. Portis T., Longnecker R. Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J. Virol. 77:2003;105-114.
26. Tarlington D.M., Smith K.G.C. Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal center. Immunol. Today. 21:2000;436-441.
27. Defrance T., et al. The life and death of a B cell. Adv. Cancer Res. 86:2002;195-225.
28. Guzman-Rojas L., et al. Life and death within germinal centres: a double-edged sword. Immunology. 107:2002;167-175.
29. Bargou R.C., et al. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 100:1997;2961-2969.
30. Krappmann D., et al. Molecular mechanisms of constitutive NF-κB/ Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene. 18:1999;943-953.
31. Kilger E., et al. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17:1998;1700-1709.
32. Fielding C.A., et al. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways. J. Virol. 75:2001;9129-9141.
33. Bishop G.A., Hostager B.S. Signaling by CD40 and its mimics in B cell activation. Immunol. Res. 24:2001;97-109.
34. Horie R., et al. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am. J. Pathol. 160:2002;1647-1654.
35. Horie R., et al. Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin-Reed-Sternberg cells. Oncogene. 21:2002;2493-2503.
36. Durkop H., et al. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation. J. Pathol. 200:2003;214-221.
37. Jungnickel B., et al. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma. J. Exp. Med. 191:2000;395-402.
38. Weiss L.M., et al. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 320:1989;502-506.
39. Hsu J.L., Glaser S.L. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit. Rev. Oncol. Hematol. 34:2000;27-53.
40. Herling M., et al. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: Associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin. Cancer Res. 9:2003;2114-2120.
41. Siegler G., et al. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma. Mol. Pathol. 56:2003;156-161.
42. Skinnider B.F., Mak T.W. The role of cytokines in classical Hodgkin lymphoma. Blood. 99:2002;4283-4297.
43. Skinnider B.F., et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 97:2001;250-255.
44. Skinnider B.F., et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 99:2002;618-626.
45. Küppers R., et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J. Clin. Invest. 111:2003;529-537.